{"id":"W2962768820","doi":"10.1016/j.lungcan.2019.07.021","title":"The rate of occurrence, healthcare resource use and costs of adverse events among metastatic non-small cell lung cancer patients treated with first- and second-generation epidermal growth factor receptor tyrosine kinase inhibitors","year":2019,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"AstraZeneca","keywords":"Medicine; Erlotinib; Afatinib; Adverse effect; Internal medicine; Gefitinib; Lung cancer; Population; Epidermal growth factor receptor; Rate ratio; Cancer; Oncology; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000307356,0.0001464447,0.0003567213,0.0004533186,0.0002176949,0.0005830025,0.0002013809,0.0003036845,0.001322957],"category_scores_gemma":[0.0018513,0.0001270003,0.001296617,0.0008123186,0.0001160974,0.0003609188,0.0002900781,0.0007242623,0.00008322426],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007968768,"about_ca_system_score_gemma":0.00049035,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006400476,"about_ca_topic_score_gemma":0.007591874,"domain_scores_codex":[0.9995657,0.0001027721,0.00007953772,0.00007036391,0.00009835544,0.00008329966],"domain_scores_gemma":[0.9985958,0.0002852765,0.0007809434,0.00003989267,0.0001114709,0.000186763],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006630194,0.00005029552,0.9953701,0.00004149778,0.0003781861,0.00009081115,0.00001696161,0.0003239919,0.0001826308,0.00004618903,0.000248232,0.002588034],"study_design_scores_gemma":[0.00001177274,0.0001273675,0.998511,0.000008665798,0.00009839467,0.0002180686,0.00007353603,0.0006253681,0.0000505332,0.00004052928,0.0002293055,0.000005488935],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9953441,0.00182297,0.00008461532,0.0001392872,0.00001650688,0.00001043485,0.001833202,0.000004358164,0.0007446007],"genre_scores_gemma":[0.9986135,0.0003841254,0.00003484826,0.0000419926,0.00001653064,0.000007110364,0.0007616034,0.000001087743,0.0001392797],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006400476,"threshold_uncertainty_score":0.01272643,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01153341486082002,"score_gpt":0.2730662465461996,"score_spread":0.2615328316853796,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}